These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27503751)

  • 21. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound.
    Zhou JH; Li AH; Cao LH; Jiang HH; Liu LZ; Pei XQ; Han F
    Br J Radiol; 2008 Feb; 81(962):113-9. PubMed ID: 18070827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver cirrhosis: evaluation of haemodynamic changes using an ultrasound contrast agent.
    Giuseppetti GM; Argalia G; Abbattista T
    Eur J Radiol; 2004 Jul; 51(1):27-33. PubMed ID: 15186881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases--a prospective randomized study in patients with chronic liver damage.
    Kanematsu M; Semelka RC; Matsuo M; Kondo H; Enya M; Goshima S; Moriyama N; Hoshi H
    Radiology; 2002 Nov; 225(2):407-15. PubMed ID: 12409573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of the Hepatic Transit Time (HTT) in Evaluation of Portal Vein Pressure in Gastroesophageal Varices Patients.
    Lin YQ; Jiang B; Li HQ; Jin CX; Wang H
    J Ultrasound Med; 2019 Sep; 38(9):2305-2314. PubMed ID: 30609088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of signal intensity from the accumulated microbubbles in the liver for differentiation of idiopathic portal hypertension from liver cirrhosis.
    Maruyama H; Ishibashi H; Takahashi M; Imazeki F; Yokosuka O
    Radiology; 2009 Aug; 252(2):587-94. PubMed ID: 19508988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast-enhanced ultrasound and computerized tomography perfusion imaging of a liver fibrosis-early cirrhosis in dogs.
    Liu H; Liu J; Zhang Y; Liao J; Tong Q; Gao F; Hu Y; Wang W
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1604-10. PubMed ID: 26878817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive diagnosis of compensated cirrhosis using an analysis of the time-intensity curve portal vein slope gradient on contrast-enhanced ultrasonography.
    Goto Y; Okuda K; Akasu G; Kinoshita H; Tanaka H
    Surg Today; 2014 Aug; 44(8):1496-505. PubMed ID: 24136649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study.
    Park MS; Hong S; Lim YL; Kang SH; Baik SK; Kim MY
    Gut Liver; 2018 Sep; 12(5):555-561. PubMed ID: 29699059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obliteration of gastric varices improves the arrival time of ultrasound contrast agents in hepatic artery and vein.
    Furuichi Y; Moriyasu F; Sugimoto K; Taira J; Sano T; Miyata Y; Sofuni A; Itoi T; Nakamura I; Imai Y
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1526-31. PubMed ID: 23611144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis.
    Qu EZ; Zhang YC; Li ZY; Liu Y; Wang JR
    J Ultrasound Med; 2014 Nov; 33(11):1971-7. PubMed ID: 25336484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging.
    Bang N; Nielsen MB; Rasmussen AN; Osterhammel PA; Pedersen JF
    Br J Radiol; 2001 Aug; 74(884):752-5. PubMed ID: 11511501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does hepatic vein transit time performed with contrast-enhanced ultrasound predict the severity of hepatic fibrosis?
    Tang A; Kim TK; Heathcote J; Guindi M; Jang HJ; Karshafian R; Burns PN; Wilson SR
    Ultrasound Med Biol; 2011 Dec; 37(12):1963-9. PubMed ID: 22033130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of focal liver lesions by means of assessment of hepatic transit time with contrast-enhanced US.
    Zhou X; Liu JB; Luo Y; Yan F; Peng Y; Lin L; Zhuang H
    Radiology; 2010 Aug; 256(2):648-55. PubMed ID: 20656845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic and morphologic changes of peripheral hepatic vasculature in cirrhotic liver disease: a preliminary study using contrast-enhanced coded phase inversion harmonic ultrasonography.
    Zheng RQ; Zhang B; Kudo M; Sakaguchi Y
    World J Gastroenterol; 2005 Oct; 11(40):6348-53. PubMed ID: 16419164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive analysis of portal pressure by contrast-enhanced sonography in patients with cirrhosis.
    Zhang CX; Hu J; Hu KW; Zhang C; Wang L; Xu JM
    J Ultrasound Med; 2011 Feb; 30(2):205-11. PubMed ID: 21266558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrograde detection of the intrahepatic portal vein in primary biliary cirrhosis: is sinusoidal blockage the underlying pathophysiology?
    Maruyama H; Kondo T; Sekimoto T; Takahashi M; Fujiwara K; Imazeki F; Yokosuka O
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):321-7. PubMed ID: 25563140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers.
    Hohmann J; Müller C; Oldenburg A; Skrok J; Frericks BB; Wolf KJ; Albrecht T
    Ultrasound Med Biol; 2009 Sep; 35(9):1427-35. PubMed ID: 19540656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography.
    Jeong WK; Kim TY; Sohn JH; Kim Y; Kim J
    PLoS One; 2015; 10(3):e0121601. PubMed ID: 25798930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Color Doppler velocity profile and contrast-enhanced ultrasonography in assessment of liver cirrhosis.
    Lin LW; Duan XJ; Wang XY; Xue ES; He YM; Gao SD; Yu LY
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):34-9. PubMed ID: 18234636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
    Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
    J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.